Search research articles
Contact Us
Filters
Showing results (381-390 of 516) with videos related to
Page
of 52
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline
Lisa K Hicks, Hans J Messersmith, Samer Al Hadidi, et al.
Leukemia
|
May 5, 2023
Relationship among three common hematological premalignant conditions
Nicholas J Boddicker, Sameer A Parikh, Aaron D Norman, et al.
Leukemia
|
April 9, 2024
Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures
Saurabh Zanwar, Morie A Gertz, Eli Muchtar, et al.
Blood Cancer Journal
|
July 23, 2024
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma
Matthew J Rees, Aytaj Mammadzadeh, Abiola Bolarinwa, et al.
Bone Marrow Transplantation
|
August 9, 2018
Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response
M Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
American Journal of Hematology
|
January 2, 2023
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience
Karan L Chohan, Jonas Paludo, Nishanth Vallumsetla, et al.
American Journal of Hematology
|
August 11, 2016
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma
Paolo Milani, S Vincent Rajkumar, Giampaolo Merlini, et al.
Blood Advances
|
July 9, 2021
Prognostic impact of posttransplant FDG PET/CT scan in multiple myeloma
Marcella Kaddoura, David Dingli, Francis K Buadi, et al.
Therapeutic Advances in Hematology
|
April 25, 2022
The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain
Hoi Ki Karen Tang, Chi Yeung Fung, Gareth J Morgan, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 2, 2012
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases
Nelson Leung, Morie Gertz, Robert A Kyle, et al.
Page
of 52
Search research articles
Search
Showing results (381-390 of 516) with videos related to
Sort By:
Page
of 52
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline
Lisa K Hicks, Hans J Messersmith, Samer Al Hadidi, et al.
Leukemia
|
May 5, 2023
Relationship among three common hematological premalignant conditions
Nicholas J Boddicker, Sameer A Parikh, Aaron D Norman, et al.
Leukemia
|
April 9, 2024
Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures
Saurabh Zanwar, Morie A Gertz, Eli Muchtar, et al.
Blood Cancer Journal
|
July 23, 2024
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma
Matthew J Rees, Aytaj Mammadzadeh, Abiola Bolarinwa, et al.
Bone Marrow Transplantation
|
August 9, 2018
Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response
M Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
American Journal of Hematology
|
January 2, 2023
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience
Karan L Chohan, Jonas Paludo, Nishanth Vallumsetla, et al.
American Journal of Hematology
|
August 11, 2016
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma
Paolo Milani, S Vincent Rajkumar, Giampaolo Merlini, et al.
Blood Advances
|
July 9, 2021
Prognostic impact of posttransplant FDG PET/CT scan in multiple myeloma
Marcella Kaddoura, David Dingli, Francis K Buadi, et al.
Therapeutic Advances in Hematology
|
April 25, 2022
The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain
Hoi Ki Karen Tang, Chi Yeung Fung, Gareth J Morgan, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 2, 2012
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases
Nelson Leung, Morie Gertz, Robert A Kyle, et al.
Page
of 52